NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
Conditions: Borderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Ductal Adenocarcinoma; Stage III Pancreatic Cancer AJCC v8 Interventions: Other: Hafnium Oxide-containing Nanoparticles NBTXR3; Radiation: Radiation Therapy Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Nanotechnology | Pancreas | Pancreatic Cancer | Radiation Therapy | Research